Global Dental Biomaterials Market to 2027 - Injectable Biomaterials for Dental Tissue Engineering Presents Opportunities

News provided by

Mar 31, 2022, 08:45 ET

DUBLIN, March 31, 2022 /PRNewswire/ -- The "Dental Biomaterials Market Research Report by Product, by Material, by Application, by End-User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Dental Biomaterials Market size was estimated at USD 7,074.94 million in 2020, is expected to reach USD 7,655.54 million in 2021, and is projected to grow at a CAGR of 8.57% to reach USD 12,582.13 million by 2027.

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Dental Biomaterials to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Bone Graft Materials, Dental Membranes, and Soft Tissue Regeneration.
Based on Material, the market was studied across Ceramics, Composites, Metals, and Polymers.
Based on Application, the market was studied across Implantology and Periodontology.
Based on End-User, the market was studied across Dental Clinics and Hospitals.
Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Dental Biomaterials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Dental Biomaterials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dental Biomaterials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dental Biomaterials Market?
4. What is the competitive strategic window for opportunities in the Global Dental Biomaterials Market?
5. What are the technology trends and regulatory frameworks in the Global Dental Biomaterials Market?
6. What is the market share of the leading vendors in the Global Dental Biomaterials Market?
7. What modes and strategic moves are considered suitable for entering the Global Dental Biomaterials Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence rate of dental disorders
5.1.1.2. Increasing disposable income in developing countries
5.1.1.3. Potential demand for dental bone grafts and dental implants globally
5.1.2. Restraints
5.1.2.1. High operational cost of dental procedures
5.1.3. Opportunities
5.1.3.1. Injectable biomaterials for dental tissue engineering
5.1.3.2. Growing dental tourism in the emerging markets
5.1.4. Challenges
5.1.4.1. Standardization and regulation of biomaterials
5.2. Cumulative Impact of COVID-19

6. Dental Biomaterials Market, by Product
6.1. Introduction
6.2. Bone Graft Materials
6.3. Dental Membranes
6.4. Soft Tissue Regeneration

7. Dental Biomaterials Market, by Material
7.1. Introduction
7.2. Ceramics
7.3. Composites
7.4. Metals
7.5. Polymers

8. Dental Biomaterials Market, by Application
8.1. Introduction
8.2. Implantology
8.3. Periodontology

9. Dental Biomaterials Market, by End-User
9.1. Introduction
9.2. Dental Clinics
9.3. Hospitals

10. Americas Dental Biomaterials Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Dental Biomaterials Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Dental Biomaterials Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. 3M Company
14.2. ACE Surgical Supply Co. Inc.
14.3. BEGO Medical GmbH
14.4. BioHorizons IPH, Inc.
14.5. Biomatlante SARL
14.6. Cam Bioceramics B.V
14.7. Carpenter Technology Corporation
14.8. Collagen Matrix Inc.
14.9. Datum Dental Ltd
14.10. Dentsply Sirona
14.11. GC Corporation
14.12. Geistlich Pharma AG
14.13. Henry Schein, Inc.
14.14. Institut Straumann AG
14.15. Ivoclar Vivadent AG
14.16. Keystone Dental, Inc
14.17. Kuraray Co., Ltd
14.18. Medtronic Plc.
14.19. Mitsui Chemicals ,Inc.
14.20. Nobel Biocare Services AG
14.21. OUSIA
14.22. Royal DSM
14.23. Straumann Holding AG
14.24. Victrex Plc
14.25. Zimmer Biomet

15. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ehis6o